248 related articles for article (PubMed ID: 32283064)
1. Adipokines as novel biomarkers of cardio-metabolic disorders.
Su X; Peng D
Clin Chim Acta; 2020 Aug; 507():31-38. PubMed ID: 32283064
[TBL] [Abstract][Full Text] [Related]
2. Emerging functions of adipokines in linking the development of obesity and cardiovascular diseases.
Su X; Peng D
Mol Biol Rep; 2020 Oct; 47(10):7991-8006. PubMed ID: 32888125
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk of adipokines: a review.
Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC
J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138
[TBL] [Abstract][Full Text] [Related]
4. Adipokines as novel biomarkers and regulators of the metabolic syndrome.
Deng Y; Scherer PE
Ann N Y Acad Sci; 2010 Nov; 1212():E1-E19. PubMed ID: 21276002
[TBL] [Abstract][Full Text] [Related]
5. New insights of acylation stimulating protein in modulating the pathological progression of metabolic syndromes.
Lian X; Cheng Y; Kang H
Int Immunopharmacol; 2024 May; 132():112018. PubMed ID: 38588630
[TBL] [Abstract][Full Text] [Related]
6. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.
Fuster JJ; Ouchi N; Gokce N; Walsh K
Circ Res; 2016 May; 118(11):1786-807. PubMed ID: 27230642
[TBL] [Abstract][Full Text] [Related]
7. Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements.
Kumari B; Yadav UCS
Curr Mol Med; 2018; 18(2):116-125. PubMed ID: 29974830
[TBL] [Abstract][Full Text] [Related]
8. An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome.
Kumari R; Kumar S; Kant R
Diabetes Metab Syndr; 2019; 13(4):2409-2417. PubMed ID: 31405652
[TBL] [Abstract][Full Text] [Related]
9. Adipokines: A Rainbow of Proteins with Metabolic and Endocrine Functions.
Parrettini S; Cavallo M; Gaggia F; Calafiore R; Luca G
Protein Pept Lett; 2020; 27(12):1204-1230. PubMed ID: 32370702
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue and metabolic syndrome: too much, too little or neither.
Grundy SM
Eur J Clin Invest; 2015 Nov; 45(11):1209-17. PubMed ID: 26291691
[TBL] [Abstract][Full Text] [Related]
11. The effect of increasing tertiles of waist circumference on cardio-metabolic risk, adipokines and biomarkers of inflammation and oxidative stress in nascent metabolic syndrome.
Jialal I; Jialal G; Devaraj S; Adams-Huet B
J Diabetes Complications; 2018 Apr; 32(4):379-383. PubMed ID: 29478813
[TBL] [Abstract][Full Text] [Related]
12. Adipokines in inflammation and metabolic disease.
Ouchi N; Parker JL; Lugus JJ; Walsh K
Nat Rev Immunol; 2011 Feb; 11(2):85-97. PubMed ID: 21252989
[TBL] [Abstract][Full Text] [Related]
13. Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.
de Oliveira Dos Santos AR; de Oliveira Zanuso B; Miola VFB; Barbalho SM; Santos Bueno PC; Flato UAP; Detregiachi CRP; Buchaim DV; Buchaim RL; Tofano RJ; Mendes CG; Tofano VAC; Dos Santos Haber JF
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807959
[TBL] [Abstract][Full Text] [Related]
14. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases.
Francisco V; Ruiz-Fernández C; Pino J; Mera A; González-Gay MA; Gómez R; Lago F; Mobasheri A; Gualillo O
Biochem Pharmacol; 2019 Jul; 165():196-206. PubMed ID: 30910694
[TBL] [Abstract][Full Text] [Related]
15. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
Pahwa R; Adams-Huet B; Jialal I
J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
[TBL] [Abstract][Full Text] [Related]
16. Melatonin Supplementation Attenuates the Pro-Inflammatory Adipokines Expression in Visceral Fat from Obese Mice Induced by A High-Fat Diet.
Farias TDSM; Paixao RID; Cruz MM; de Sa RDCDC; Simão JJ; Antraco VJ; Alonso-Vale MIC
Cells; 2019 Sep; 8(9):. PubMed ID: 31489938
[TBL] [Abstract][Full Text] [Related]
17. [Fat mass expansion, fatty acids and adipokines: metabolic markers and risk factors for cardiovascular pathologies].
Lafontan M
Ann Pharm Fr; 2013 Jan; 71(1):13-26. PubMed ID: 23348852
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory processes in obesity: focus on endothelial dysfunction and the role of adipokines as inflammatory mediators.
Singh M; Benencia F
Int Rev Immunol; 2019; 38(4):157-171. PubMed ID: 31286783
[TBL] [Abstract][Full Text] [Related]
19. Role of dysfunctional adipocytes in cholesterol-induced nonobese metabolic syndrome.
Huang JP; Hsu SC; Meir YJ; Hsieh PS; Chang CC; Chen KH; Chen JK; Hung LM
J Mol Endocrinol; 2018 May; 60(4):307-321. PubMed ID: 29581238
[TBL] [Abstract][Full Text] [Related]
20. Obesity and adipokines: effects on sympathetic overactivity.
Smith MM; Minson CT
J Physiol; 2012 Apr; 590(8):1787-801. PubMed ID: 22351630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
